Basit öğe kaydını göster

dc.contributor.authorOzbulut, O.
dc.contributor.authorEmul, M.
dc.contributor.authorKurt, E.
dc.contributor.authorGuler, O.
dc.contributor.authorSaglam, H.
dc.contributor.authorGecici, O.
dc.contributor.authorErdur, F.
dc.date.accessioned2021-03-05T16:41:34Z
dc.date.available2021-03-05T16:41:34Z
dc.date.issued2009
dc.identifier.citationKurt E., Emul M., Ozbulut O., Guler O., Erdur F., Saglam H., Gecici O., "Is valproate promising in cardiac fatal arrhythmias? Comparison of P- and Q-wave dispersion in bipolar affective patients on valproate or lithium-valproate maintenance therapy with healthy controls", JOURNAL OF PSYCHOPHARMACOLOGY, cilt.23, ss.328-333, 2009
dc.identifier.issn0269-8811
dc.identifier.otherav_c1def84c-e8bf-4d46-86dc-d8a8a14477a4
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/128677
dc.identifier.urihttps://doi.org/10.1177/0269881108089594
dc.description.abstractAutonomic nerve system is considered to be involved in bipolar affective disorder (BAD) or to be influenced by valproate monotherapy or valproate plus lithium combination. We planned to assess the effects of medication on atrial and ventricular conduction. The electrocardiography records were performed with eligible 15 patients with valproate, 20 patients with lithium-valproate combination use in euthymic phases of BAD and 20 healthy participants. The blood valproate and lithium concentrations in groups were in normal range. The difference in P maximum, P minimum, maximum QTc were statistically insignificant. Minimum QTc (F = 6.36; df = 2; P = 0.003) and QT dispersion (QTD) (F = 5.57; df = 2; P = 0.006) were statistically significant among the groups. There were no significant differences between patient groups among ECG parameters. Minimum QTc was significantly longer in combination group than healthy controls, whereas the QTD values in both patient groups were significantly lower than controls'. Valproate might have some preventive effects on ventricular electrical conduction because of lower QTD in both patient groups. Thus, valproate seems to have cardiac conduction stabilizing effect beside its mood stabilizing aspect. However, this finding needs replication and further corroboration in well-designed studies.
dc.language.isoeng
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectNöroloji
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectKLİNİK NEUROLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectNEUROSCIENCES
dc.subjectSinirbilim ve Davranış
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectPsikiyatri
dc.titleIs valproate promising in cardiac fatal arrhythmias? Comparison of P- and Q-wave dispersion in bipolar affective patients on valproate or lithium-valproate maintenance therapy with healthy controls
dc.typeMakale
dc.relation.journalJOURNAL OF PSYCHOPHARMACOLOGY
dc.contributor.departmentIstanbul Bakirkoy Mental Health & Neurology Training & Research Hospital , ,
dc.identifier.volume23
dc.identifier.issue3
dc.identifier.startpage328
dc.identifier.endpage333
dc.contributor.firstauthorID192330


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster